Identification of AV-1451 as a Weak, Nonselective Inhibitor of Monoamine Oxidase

doi 10.1021/acschemneuro.9b00326.s001
Full Text
Abstract

Available in full text

Date

Unknown

Authors

Unknown

Publisher

American Chemical Society (ACS)

Related search

Unusual Reaction to Monoamine Oxidase Inhibitor.

BMJ
1979English

A Sensitive Fluorometric Assay of Human Platelet Monoamine Oxidase and Its Application to Assessment of Monoamine Oxidase Inhibitor.

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1978English

Pharmacodynamics of Lazabemide, a Reversible and Selective Inhibitor of Monoamine Oxidase B.

British Journal of Clinical Pharmacology
Pharmacology
1994English

Effect of Monoamine Oxidase Inhibitor on Developmental Mechanism in the Amphibian

The Japanese Journal of Pharmacology
1965English

Modification of Insulin and Sulfonylurea Hypoglycemia by Monoamine-Oxidase Inhibitor Drugs

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
1967English

Tyramine in Malt Beverages Interfering With Monoamine Oxidase Inhibitor Drugs

Journal of Biosciences and Medicines
2016English

A Hypothesis for an Alternative Treatment for Tobacco Addiction: Phenelzine, a Monoamine Oxidase Inhibitor

Tobacco Induced Diseases
MedicineEnvironmentalPublic HealthHealthOccupational Health
2018English

Monoamine Oxidase Inhibition

Biochemical Society Transactions
Biochemistry
1994English

2-Acetylphenol Analogs as Potent Reversible Monoamine Oxidase Inhibitors

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy